Tantalum radiopacity in liquid embolics is one of the most important — and least discussed — engineering elements behind modern embolization procedures. Because ethylene vinyl alcohol (EVOH) copolymer itself is not visible under X-ray imaging, manufacturers add micronized tantalum powder so that interventional radiologists can watch the embolic agent in real time as it travels through the vasculature. This article explains what tantalum is, why it is used, and how radiopacity shapes the safety workflow of liquid embolization.
What Is Tantalum and Why Is It Used in Medical Devices?
Tantalum is a dense, corrosion-resistant metallic element with a long history in implantable and interventional devices. Its key properties for embolization include:
- High atomic number and density, which strongly attenuate X-rays and produce clear contrast under fluoroscopy.
- Established biocompatibility, with decades of use in device applications described in the engineering literature.
- Chemical stability, resisting corrosion in physiological environments.
In liquid embolic formulations, micronized tantalum powder is suspended in the EVOH–DMSO solution. When the mixture is injected and the DMSO diffuses away, the precipitating polymer retains the tantalum particles, keeping the cast visible during and after delivery.
Why Does Visibility Matter During Embolization?
Embolization is a flow-directed therapy. The operator must see where the embolic agent is going at every moment to work toward occluding the intended target — such as a cerebral arteriovenous malformation (AVM) nidus or a hypervascular tumor's feeding arteries — while monitoring for any movement of material toward vessels that must stay open. Real-time fluoroscopic visibility supports:
- Controlled, incremental injection, allowing the operator to pause when the cast approaches non-target territory.
- Assessment of penetration, observing how the material distributes within the target vasculature.
- Documentation of the final cast, providing a reference for follow-up imaging.
INVAMED's LIBRO EVOH liquid embolic agent, available in 6% and 8% concentrations, uses tantalum-enhanced fluoroscopic visibility for this purpose. As with all embolic devices, suitability for a given case is determined by the treating physician team, and no device feature can guarantee a specific outcome.
How Do Concentration and Radiopacity Interact?
EVOH concentration primarily influences viscosity and flow behavior, while the tantalum component addresses visibility. Physicians in the published literature generally describe lower-concentration formulations as traveling more distally and higher-concentration formulations as forming more proximal, controlled casts. The radiopacifier load is designed so that both behave predictably under imaging. Operators typically shake or mix the vial per the Instructions for Use (IFU) before delivery so the tantalum remains evenly suspended — a settled suspension can produce uneven visibility.
What Should Teams Know About Imaging Artifacts?
Dense tantalum casts can create beam-hardening or streak artifacts on follow-up CT imaging, a practical consideration radiology teams factor into post-procedure assessment. MRI compatibility considerations are described in each product's IFU and should always be reviewed before follow-up imaging is planned.
Frequently Asked Questions
Does tantalum stay in the body after embolization?
The tantalum particles remain bound within the solidified polymer cast at the treated site. Their long-term presence is part of the device's design and is described in the product documentation reviewed during regulatory assessment.
Is tantalum the only radiopacifier used in embolic devices?
No. Other radiopaque strategies exist across the device landscape — for example, platinum in coils or iodinated contrast mixed with some materials — but tantalum is the established choice for EVOH-based liquid embolics.
Can patients feel the tantalum in a liquid embolic?
The embolic cast, including its tantalum component, resides inside the treated vessels. Questions about individual sensations or symptoms after embolization should always be directed to the treating physician.
Related INVAMED Resources
- Embolization portfolio — plugs, coils, and liquid embolic systems
- Neurovascular Interventions — microcatheters used for liquid embolic delivery
- Request Information — contact INVAMED about LIBRO EVOH availability in your region
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.